Adimmune Corporation(TW:4142)
NT$16.60-0.20 (-1.19%)
TW:4142
Adimmune Corporation Revenue
NT$16.60
At close:-0.20 (-1.19%)
Adimmune Corporation (4142) Revenue
Adimmune Corporation Revenue
Adimmune Corporation had a revenue of 66.76M in the quarter ending Jun 30, 2026, with -18.90%. This bring the company's revenue in the last twelve months to 1.37B, Decreased 2.96%. In the fiscal year ending Dec 31, 2025, Adimmune Corporation had annual revenue of 1.40B with -9.99% growth.
- Revenue (ttm)
- 1.37B
- Revenue Growth
- 34.06%
- P/S Ratio
- 5.15
- Revenue/Employee
- TWD 2,484,931
- Employees
- 564
- Market Cap
- TWD 7.22B
Revenue Chart
Adimmune Corporation Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.40B | -155.49M | -9.99% |
| Dec 31, 2024 | 1.56B | -228.10M | -12.78% |
| Dec 31, 2023 | 1.79B | -466.53M | -20.72% |
| Dec 31, 2022 | 2.25B | 610.56M | 37.21% |
| Dec 31, 2021 | 1.64B | -228.09M | -12.20% |
| Dec 31, 2020 | 1.87B | 569.46M | 43.81% |
| Dec 31, 2019 | 1.30B | 477.32M | 58.04% |
| Dec 31, 2018 | 822.37M | 259.62M | 46.14% |
| Dec 31, 2017 | 562.74M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.